Neuropathological links between plasma p-Tau 181, white matter hyperintensity, and structural brain changes in aging

Background: White matter hyperintensity (WMH) has been reported to be associated with brain structure changes and Alzheimer’s disease (AD) pathology in the aging process. This study sought to explore the underlying mechanisms linking cerebrovascular pathology, structural brain changes, and AD pathology in the aging process. Methods: The routine magnetic resonance images of 218 cognitively normal elderly individuals who underwent venous blood sampling were retrospectively collected. The Fazekas score was used to stratify the cohort into mild (Fazekas scores of 0–1, n=113) and severe (Fazekas scores of 2–3, n=105) WMH groups. All the three-dimensional (3D) T1-weighted (T1W) images, including the original 3D T1W images and the 3D T1W images reconstructed from two-dimensional (2D) diagnostic images, were processed with FreeSurfer to determine the cortical thickness and subcortical nucleus volumes. The plasma amyloid-beta (Aβ)42 and phosphorylated tau (p-Tau) 181 levels were measured by enzyme-linked immunosorbent assay (ELISA). The cerebral small vessel disease (CSVD)-related imaging markers were assessed manually. Group comparisons of brain structures were performed using general linear models (GLMs). Partial correlation analyses were conducted to assess the associations between plasma Aβ42/p-Tau 181 and the subcortical volumes. A mediation analysis was conducted to evaluate the mediating role of the WMH burden in the relationship between plasma biomarker levels and brain structure. Results: The participants with severe WMH were older (P